Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive procedures in CAD cases, and the advent of technologically advanced, premium-priced diagnostic and treatment devices that offer case-specific diagnosis and intervention for CAD cases of varying complexity. Going forward, the Asia Pacific IC device market is expected to expand moderately, driven by the growth in the coronary stent, balloon, and intravascular imaging and pressure guidewire segments.

This Medtech 360 Report provides comprehensive data and analysis on the state of the interventional cardiology device market in Asia Pacific from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Europe
The diagnostic imaging system market in Europe is expected to experience gradual growth through 2034, supported by the continued rollout of advanced technologies, rising adoption of AI-driven…
Report
Hernia Repair Devices – Market Insights – Global
The global market for hernia repair devices is expected to grow modestly over the forecast period. This growth is primarily driven by an increase in hernia repair procedures, with a notable shift…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Aortic Repair Devices – Market Insights – United States
The US aortic repair device market will grow moderately during upcoming years, driven by the uptake of innovative stent grafts and the positive clinical evidence that supports their adoption. The…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…